Financials

News Ideas Discussions Technicals Seasonals

NLSP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to NLS Pharmaceutics Ltd. operating, investing, and financing activities

NLSP free cash flow for H2 24 is -2.74 M USD. For 2024, NLSP free cash flow was -4.27 M USD and operating cash flow was -4.27 M USD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—